Novartis AG (NVS)

NYSEHealthcare

$153.99
-$1.09 (-0.7%)
Market closed

April 2, 2026 at 20:00 UTC

Interactive Chart

NVS
1H
3H
6H
12H
1D
1W
1M
3M
6M
1Y
2Y
5Y
All

16:52:33 UTC

About Novartis AG

Name
Novartis AG
CEO
Vasant Narasimhan
Industry
Healthcare
Year Founded
1996
Employees
75,883

Novartis AG is a pharmaceutical company that discovers, develops, and supplies medicines for conditions managed in specialty and primary care. Its model connects research with manufacturing and patient access so new therapies move from trials to practice under consistent standards. Programs focus on areas where evidence, careful dosing, and long follow-up matter, which is why labeling clarity and clinician education sit alongside science as core work. Supply chains and quality systems are organized for continuity rather than spectacle, keeping availability steady once treatment becomes part of care. Country teams adapt to local frameworks while holding to shared safety principles. Within the healthcare sector, Novartis acts as a long-horizon manufacturer and science organization, turning complex research into options that clinicians can use predictably in hospitals and clinics around the world.

Analyst Ratings

Consensus Recommendation
Analyst consensus: 10 Buy, 6 Hold, 7 Sell
Buy10
Hold6
Sell7

Fundamentals & Financials

Revenue (TTM)
$56.1B
Net Income (TTM)
$13.9B
EPS (TTM)
$7.2
ROA (TTM)
12.13%
Current Ratio
1.12
Dividend Yield
0.097%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

ItemQ4 2025
Revenue$13,334.9M
Cost of Sales$3,541.7M
Gross Profit$9,793.2M
Operating Income$3,520.7M
Net Income$2,408.8M
EPS$1.26

Technical Indicators

Novartis AG's Technical Indicators Summary

Novartis presents a neutral technical stance where price is above shorter-term moving averages and well above longer-term levels, yet momentum and trend indicators are mixed. RSI and MACD sit near neutral, while ADX suggests a modest trend that has not decisively favored either side. Volatility is subdued and on-balance volume is not providing clear support, and the pivot sits slightly above the market. Technical takeaway: Neutral — mixed momentum and moderate trend strength keep the technical outlook balanced.

Buy
10 signals
Neutral
6 signals
Sell
7 signals
Overall: Neutral26% Neutral signals
IndicatorValue
RSI (14)
50.46
Stochastic %K (14, 3, 3)
80.53
CCI (20)
19.42
WPR (14)
-19.02
Momentum (10)
5.84
MFI
51.11
MACD Level (12, 26)
-1.49
Bollinger Bands
$143.63 - $162.30
ATR (14)
$2.99 (1.94%)
ADX (14)
28.13
OBV
28,247,800
Classic Pivot Point
$155.09
Fibonacci Pivot Point
$155.09
Simple Moving Averages
$134.57 - $156.20(5 indicators)
Exponential Moving Averages
$136.35 - $153.28(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

By the close, NVS continued to sit slightly below yesterday’s 155.08, with a small -0.68% gap down and a finish near 154.03. Into the bell, NVS was moving toward an earnings checkpoint, now 25 days out on 28 April. NVS trades modestly lower as investors await its upcoming earnings checkpoint.

Price Change

from $153.99 close

+$0

Trading Volume

Above avg 1.8M

2.5M

vs S&P 500 Today

Underperforming Market

-1.16%

52-Week Position

Upper range

77.4%

Updated: April 3, 2026 at 20:09 UTC

Quote Summary

OpenPrevious Close
$153.37$153.99
Day Range52 Week Range
$153.18 - $154.81$97.72 - $170.46
VolumeAvg. Volume
2.5M2.3M
Market CapP/E Ratio
$297.3B21.5